Altria Group, Inc. MO

Fortune today announced an additional group of speakers for the Fortune 500 Innovation Forum, November 16–17, 2026, in Detroit, Michigan. The newly confirmed leaders will join CEOs, entrepreneurs, policymakers, investors, and civic innovators from across the country for conversations about the forces reshaping American business, technology, work, manufacturing, and prosperity.

Rising rates have boomers flocking to Treasuries, but five battle-tested dividend payers with 50-plus years of consecutive increases may offer something bonds simply cannot deliver.

Three stocks all yield above 5% and all carry decades of unbroken dividend payments, but each one asks you to accept a completely different kind of risk before that income hits your account.

Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.

Philip Morris and Altria both just raised their dividends, but the gap between them runs far deeper than yield percentages and payout sizes. Which tobacco giant actually deserves a spot in a retirement portfolio built to last a decade?

With the stock market leaning hard on one shaky pillar and U.S. debt crossing $40 trillion, a 57-year-old dividend stalwart from an industry everyone loves to hate might be the safest place to park your money right now.

Most investors settle for the S&P 500's average 1.3% yield without realizing a handful of index giants quietly pay four times that amount, and a few of them have raised their dividends for decades straight.

Fed officials are still talking tough on inflation, rate expectations keep shifting, and political noise around interest cuts is getting louder. As a result, investors are being forced to rethink where to park cash for income and relative calm. That stress creates a window. Strong free cash flow, dividends and low beta can matter more when policy is tight. This article walks through 3 large cap value stocks that screens suggest could be especially exposed to these cross currents. The three...

Investing.com -- The Trump administration is preparing a major regulatory shift to accelerate market authorization for smoke-free nicotine products, according to reporting by The Wall Street Journal. The Food and Drug Administration is expected to announce changes easing the requirements of its 2021 premarket review framework in coming days, establishing a streamlined regulatory pathway for alternative nicotine delivery systems.

A fat dividend yield can signal a screaming buy or a slow-motion disaster, and the difference hides in coverage math most investors never check. Six well-known names are flashing the exact warning signs that tend to show up just before a payout gets cut.

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.